Brief: Agile Therapeutics Determined It Incorrectly Classified Certain Warrants That Were Issued To Investors In Connection With Offering Of Common Stock

Agile Therapeutics

27/02/2023 13:44

Feb 27 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * DETERMINED IT INCORRECTLY CLASSIFIED CERTAIN WARRANTS THAT
WERE
ISSUED TO INVESTORS IN CONNECTION WITH OFFERING OF COMMON STOCK
    * WARRANTS WERE IMPROPERLY CLASSIFIED IN EQUITY AND SHOULD
HAVE
BEEN RECORDED AS LIABILITIES
    * COMPANY ESTIMATES THAT NET LOSS WAS OVERSTATED IN EACH
PERIOD
    * EXPECTS THE ERRORS TO HAVE NO EFFECT ON COMPANY'S
PREVIOUSLY
REPORTED REVENUE, OPERATING EXPENSES, CASH FLOWS OR CASH
    * WORKING TO COMPLETE FILING OF DEC 31, 2022 ANNUAL REPORT
ON FORM
10-K AS SOON AS PRACTICABLE, WHICH WILL INCLUDE RESTATEMENTS


Further company coverage:  AGRX.O 

 ((Reuters.Briefs@thomsonreuters.com))